(+)-pilocarpine increases expression EXP 6480464 Pilocarpine results in increased expression of CTSD mRNA CTD PMID:17971868 (-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 epigallocatechin gallate inhibits the reaction [Isoproterenol affects the activity of CTSD protein] CTD PMID:18294627 (-)-epigallocatechin 3-gallate increases expression ISO RGD:1351014 6480464 epigallocatechin gallate results in increased expression of CTSD protein CTD PMID:31195006 (R)-linalyl acetate multiple interactions ISO RGD:1351014 6480464 Fulvestrant inhibits the reaction [linalyl acetate results in increased expression of CTSD mRNA] CTD PMID:31393563 (R)-linalyl acetate increases expression ISO RGD:1351014 6480464 linalyl acetate results in increased expression of CTSD mRNA CTD PMID:31393563 (R)-lipoic acid multiple interactions EXP 6480464 Thioctic Acid inhibits the reaction [Doxorubicin results in decreased activity of CTSD protein] CTD PMID:12841641 (R,R,R)-alpha-tocopherol increases expression EXP 6480464 alpha-Tocopherol results in increased expression of CTSD protein CTD PMID:18942769 (S)-amphetamine decreases expression ISO RGD:732637 6480464 Dextroamphetamine results in decreased expression of CTSD mRNA CTD PMID:12558987 (S)-naringenin multiple interactions ISO RGD:1351014 6480464 [naringenin results in increased phosphorylation of and results in increased activity of ESR1 protein] which results in increased expression of CTSD mRNA CTD PMID:24586459 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO RGD:1351014 6480464 o, p'-DDT results in increased expression of CTSD mRNA CTD PMID:22609851 1,2,4-trimethylbenzene decreases expression EXP 6480464 pseudocumene results in decreased expression of CTSD protein CTD PMID:17337753 1,2-dimethylhydrazine multiple interactions ISO RGD:732637 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of CTSD mRNA] CTD PMID:22206623 1,2-dimethylhydrazine increases expression ISO RGD:732637 6480464 1, 2-Dimethylhydrazine results in increased expression of CTSD mRNA CTD PMID:22206623 1,3-dichloropropan-2-ol decreases expression ISO RGD:1351014 6480464 1, 3-dichloro-2-propanol results in decreased expression of CTSD protein CTD PMID:33581215 1,8-cineole multiple interactions ISO RGD:1351014 6480464 Fulvestrant inhibits the reaction [Eucalyptol results in increased expression of CTSD mRNA] CTD PMID:31393563 1,8-cineole increases expression ISO RGD:1351014 6480464 Eucalyptol results in increased expression of CTSD mRNA CTD PMID:31393563 17beta-estradiol multiple interactions ISO RGD:1351014 6480464 3' more ... CTD PMID:10376965 more ... 17beta-estradiol increases secretion ISO RGD:1351014 6480464 Estradiol results in increased secretion of CTSD protein, Estradiol results in increased secretion of CTSD protein modified form CTD PMID:2278856 more ... 17beta-estradiol increases expression ISO RGD:1351014 6480464 Estradiol results in increased expression of CTSD mRNA, Estradiol results in increased expression of CTSD protein CTD PMID:10376965 more ... 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one decreases expression ISO RGD:1351014 6480464 Metribolone results in decreased expression of CTSD protein CTD PMID:17152098 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1351014 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CTSD mRNA more ... CTD PMID:11165043 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:732637 6480464 Tetrachlorodibenzodioxin results in decreased expression of CTSD mRNA CTD PMID:33956508 2,3,7,8-tetrachlorodibenzodioxine increases secretion ISO RGD:1351014 6480464 Tetrachlorodibenzodioxin results in increased secretion of CTSD protein CTD PMID:7909315 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:732637 6480464 Tetrachlorodibenzodioxin affects the expression of CTSD mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:732637 6480464 Tetrachlorodibenzodioxin results in increased expression of CTSD mRNA CTD PMID:11879969 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1351014 6480464 Tetrachlorodibenzodioxin results in decreased expression of CTSD mRNA CTD PMID:19619570 2-amino-2-deoxy-D-glucopyranose affects localization ISO RGD:1351014 6480464 Glucosamine affects the localization of CTSD protein CTD PMID:15972124 2-amino-2-deoxy-D-glucopyranose decreases expression ISO RGD:1351014 6480464 Glucosamine results in decreased expression of CTSD protein alternative form CTD PMID:16850161 2-amino-2-deoxy-D-glucopyranose multiple interactions ISO RGD:1351014 6480464 pepstatin inhibits the reaction [Glucosamine results in decreased expression of CTSD protein alternative form] CTD PMID:16850161 2-amino-2-deoxy-D-glucopyranose increases activity ISO RGD:1351014 6480464 Glucosamine results in increased activity of CTSD protein CTD PMID:16850161 2-butoxyethanol increases expression ISO RGD:732637 6480464 n-butoxyethanol results in increased expression of CTSD mRNA CTD PMID:19812364 2-deoxy-D-glucose increases expression EXP 6480464 Deoxyglucose results in increased expression of CTSD protein CTD PMID:20026095 2-nitrofluorene increases expression EXP 6480464 2-nitrofluorene results in increased expression of CTSD mRNA CTD PMID:15890375 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine increases activity EXP 6480464 Puromycin Aminonucleoside results in increased activity of CTSD protein CTD PMID:6497855 3,3'-diindolylmethane multiple interactions ISO RGD:1351014 6480464 3 more ... CTD PMID:28844962 3,4-methylenedioxymethamphetamine increases expression ISO RGD:732637 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of CTSD mRNA CTD PMID:20188158 3,4-methylenedioxymethamphetamine multiple interactions EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of and results in decreased activity of CTSD protein CTD PMID:32186374 3,4-methylenedioxymethamphetamine multiple interactions ISO RGD:1351014 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of and results in decreased activity of CTSD protein CTD PMID:32186374 3-methylcholanthrene increases expression ISO RGD:1351014 6480464 Methylcholanthrene results in increased expression of CTSD mRNA CTD PMID:16257430 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CTSD mRNA CTD PMID:15890375 4-nitroquinoline N-oxide multiple interactions EXP 6480464 geraniol inhibits the reaction [4-Nitroquinoline-1-oxide results in increased activity of CTSD protein] CTD PMID:23499697 4-nitroquinoline N-oxide increases activity EXP 6480464 4-Nitroquinoline-1-oxide results in increased activity of CTSD protein CTD PMID:23499697 4-nonylphenol increases expression ISO RGD:1351014 6480464 4-nonylphenol results in increased expression of CTSD protein CTD PMID:26804032 4-terpineol increases expression ISO RGD:1351014 6480464 terpinenol-4 results in increased expression of CTSD mRNA CTD PMID:31393563 4-terpineol multiple interactions ISO RGD:1351014 6480464 Fulvestrant inhibits the reaction [terpinenol-4 results in increased expression of CTSD mRNA] CTD PMID:31393563 4-tert-Octylphenol increases expression ISO RGD:1351014 6480464 4-tert-octylphenol results in increased expression of CTSD mRNA, 4-tert-octylphenol results in increased expression of CTSD protein CTD PMID:23219593 4-tert-Octylphenol multiple interactions ISO RGD:1351014 6480464 ESR1 mutant form inhibits the reaction [4-tert-octylphenol results in increased expression of CTSD mRNA], fulvestrant inhibits the reaction [4-tert-octylphenol results in increased expression of CTSD mRNA] CTD PMID:23219593 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole multiple interactions EXP 6480464 Omeprazole inhibits the reaction [Cysteamine results in increased expression of CTSD protein] CTD PMID:20165931 6alpha-methylprednisolone multiple interactions EXP 6480464 Methylprednisolone inhibits the reaction [Isoproterenol results in increased expression of CTSD mRNA] CTD PMID:894732 7,12-dimethyltetraphene increases expression EXP 6480464 9 more ... CTD PMID:12097258 acrolein multiple interactions ISO RGD:1351014 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CTSD mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CTSD mRNA CTD PMID:32699268 afimoxifene increases expression ISO RGD:1351014 6480464 afimoxifene results in increased expression of CTSD mRNA CTD PMID:15072547 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of CTSD mRNA CTD PMID:15890375 aflatoxin B1 increases methylation ISO RGD:1351014 6480464 Aflatoxin B1 results in increased methylation of CTSD intron CTD PMID:30157460 aflatoxin B1 decreases expression ISO RGD:1351014 6480464 Aflatoxin B1 results in decreased expression of CTSD mRNA CTD PMID:27153756 aflatoxin B2 decreases methylation ISO RGD:1351014 6480464 aflatoxin B2 results in decreased methylation of CTSD intron CTD PMID:30157460 aldehydo-D-glucosamine affects localization ISO RGD:1351014 6480464 Glucosamine affects the localization of CTSD protein CTD PMID:15972124 aldehydo-D-glucosamine increases activity ISO RGD:1351014 6480464 Glucosamine results in increased activity of CTSD protein CTD PMID:16850161 aldehydo-D-glucosamine decreases expression ISO RGD:1351014 6480464 Glucosamine results in decreased expression of CTSD protein alternative form CTD PMID:16850161 aldehydo-D-glucosamine multiple interactions ISO RGD:1351014 6480464 pepstatin inhibits the reaction [Glucosamine results in decreased expression of CTSD protein alternative form] CTD PMID:16850161 all-trans-retinoic acid increases expression ISO RGD:1351014 6480464 Tretinoin results in increased expression of CTSD mRNA, Tretinoin results in increased expression of CTSD protein CTD PMID:15498508 more ... all-trans-retinoic acid multiple interactions ISO RGD:1351014 6480464 Tretinoin promotes the reaction [AG 1879 results in increased expression of CTSD protein] CTD PMID:23864846 alliin multiple interactions EXP 6480464 alliin affects the reaction [Isoproterenol affects the activity of CTSD protein] CTD PMID:17623887 aloxistatin multiple interactions ISO RGD:1351014 6480464 [aloxistatin co-treated with pepstatin] results in decreased expression of CTSD protein CTD PMID:32186374 alpha-naphthoflavone multiple interactions ISO RGD:1351014 6480464 alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of CTSD mRNA]] CTD PMID:11165043 alpha-pinene multiple interactions ISO RGD:1351014 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CTSD mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CTSD mRNA CTD PMID:32699268 alpha-terpineol increases expression ISO RGD:1351014 6480464 alpha-terpineol results in increased expression of CTSD mRNA CTD PMID:31393563 amlodipine multiple interactions EXP 6480464 [Nicorandil co-treated with Amlodipine] inhibits the reaction [Isoproterenol results in decreased activity of CTSD protein], [Nicorandil co-treated with Amlodipine] inhibits the reaction [Isoproterenol results in increased activity of CTSD protein] CTD PMID:11829124 , PMID:14499179 ammonium chloride increases expression EXP 6480464 Ammonium Chloride results in increased expression of CTSD protein CTD PMID:16483693 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CTSD mRNA CTD PMID:16483693 amodiaquine decreases activity ISO RGD:1351014 6480464 Amodiaquine results in decreased activity of CTSD protein CTD PMID:24113242 anthocyanin multiple interactions EXP 6480464 Anthocyanins inhibits the reaction [Cyclophosphamide results in increased activity of CTSD protein] CTD PMID:25451569 aristolochic acid multiple interactions EXP 6480464 [aristolochic acid I co-treated with aristolochic acid II] results in decreased expression of CTSD mRNA CTD PMID:23912714 arsane decreases expression ISO RGD:1351014 6480464 Arsenic results in decreased expression of CTSD protein CTD PMID:25110733 arsenic atom decreases expression ISO RGD:1351014 6480464 Arsenic results in decreased expression of CTSD protein CTD PMID:25110733 arsenous acid multiple interactions ISO RGD:1351014 6480464 Arsenic Trioxide promotes the reaction [AG 1879 results in increased expression of CTSD protein] CTD PMID:23864846 arsenous acid increases expression ISO RGD:1351014 6480464 Arsenic Trioxide results in increased expression of CTSD protein CTD PMID:23864846 , PMID:25419056 Azaspiracid decreases metabolic processing ISO RGD:1351014 6480464 azaspiracid results in decreased metabolism of CTSD protein CTD PMID:23387425 beauvericin multiple interactions ISO RGD:1351014 6480464 [beauvericin co-treated with enniatins] results in decreased expression of CTSD protein CTD PMID:32407736 benzamide multiple interactions ISO RGD:1351014 6480464 benzamide analog inhibits the reaction [Estradiol promotes the reaction [ESR1 protein binds to CTSD promoter]], benzamide analog inhibits the reaction [Tamoxifen promotes the reaction [ESR1 protein binds to CTSD promoter]] CTD PMID:17157789 benzo[a]pyrene decreases expression ISO RGD:1351014 6480464 Benzo(a)pyrene results in decreased expression of CTSD mRNA CTD PMID:17879257 benzo[a]pyrene affects methylation ISO RGD:1351014 6480464 Benzo(a)pyrene affects the methylation of CTSD intron CTD PMID:30157460 benzo[a]pyrene decreases methylation ISO RGD:1351014 6480464 Benzo(a)pyrene results in decreased methylation of CTSD promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:1351014 6480464 fulvestrant inhibits the reaction [Benzo(a)pyrene analog results in increased expression of CTSD mRNA], fulvestrant inhibits the reaction [Benzo(a)pyrene results in increased expression of CTSD mRNA] CTD PMID:19365803 benzo[a]pyrene increases expression ISO RGD:1351014 6480464 Benzo(a)pyrene analog results in increased expression of CTSD mRNA, Benzo(a)pyrene results in increased expression of CTSD mRNA CTD PMID:19365803 benzo[a]pyrene increases expression ISO RGD:732637 6480464 Benzo(a)pyrene results in increased expression of CTSD mRNA CTD PMID:21715664 , PMID:22228805 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1351014 6480464 7 more ... CTD PMID:20382639 benzo[b]fluoranthene increases expression ISO RGD:732637 6480464 benzo(b)fluoranthene results in increased expression of CTSD mRNA CTD PMID:26377693 beta-D-glucosamine affects localization ISO RGD:1351014 6480464 Glucosamine affects the localization of CTSD protein CTD PMID:15972124 beta-D-glucosamine decreases expression ISO RGD:1351014 6480464 Glucosamine results in decreased expression of CTSD protein alternative form CTD PMID:16850161 beta-D-glucosamine multiple interactions ISO RGD:1351014 6480464 pepstatin inhibits the reaction [Glucosamine results in decreased expression of CTSD protein alternative form] CTD PMID:16850161 beta-D-glucosamine increases activity ISO RGD:1351014 6480464 Glucosamine results in increased activity of CTSD protein CTD PMID:16850161 bisphenol A multiple interactions ISO RGD:1351014 6480464 3 more ... CTD PMID:14754635 more ... bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CTSD mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1351014 6480464 bisphenol A results in increased expression of CTSD mRNA, bisphenol A results in increased expression of CTSD protein CTD PMID:26407941 more ... bortezomib increases expression ISO RGD:1351014 6480464 Bortezomib results in increased expression of CTSD mRNA CTD PMID:20977926 brucine decreases expression ISO RGD:1351014 6480464 brucine results in decreased expression of CTSD mRNA CTD PMID:23933019 brucine decreases expression ISO RGD:732637 6480464 brucine results in decreased expression of CTSD mRNA, brucine results in decreased expression of CTSD protein CTD PMID:23933019 buspirone increases expression EXP 6480464 Buspirone results in increased expression of CTSD mRNA CTD PMID:24136188 cadmium atom increases expression ISO RGD:1351014 6480464 Cadmium results in increased expression of CTSD mRNA CTD PMID:8207012 cadmium dichloride increases expression ISO RGD:1351014 6480464 Cadmium Chloride results in increased expression of CTSD, Cadmium Chloride results in increased expression of CTSD mRNA CTD PMID:20219890 , PMID:22041583 cadmium dichloride increases expression ISO RGD:732637 6480464 Cadmium Chloride results in increased expression of CTSD mRNA CTD PMID:30030080 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of CTSD mRNA CTD PMID:21297351 cadmium dichloride multiple interactions ISO RGD:1351014 6480464 Melatonin inhibits the reaction [Cadmium Chloride results in increased expression of CTSD] CTD PMID:22041583 caffeine increases expression ISO RGD:1351014 6480464 Caffeine results in increased expression of CTSD protein CTD PMID:31195006 carbon nanotube affects expression ISO RGD:732637 6480464 Nanotubes, Carbon affects the expression of CTSD mRNA CTD PMID:23845593 carbon nanotube increases expression ISO RGD:732637 6480464 Nanotubes more ... CTD PMID:25554681 chloroquine affects localization EXP 6480464 Chloroquine affects the localization of CTSD protein CTD PMID:7715800 chloroquine multiple interactions ISO RGD:1351014 6480464 [quizartinib co-treated with spautin-1 co-treated with Chloroquine] results in increased transport of and affects the localization of CTSD protein CTD PMID:30821613 chloroquine increases expression EXP 6480464 Chloroquine results in increased expression of CTSD protein CTD PMID:2759144 choline multiple interactions ISO RGD:732637 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CTSD mRNA CTD PMID:20938992 cimetidine decreases activity EXP 6480464 Cimetidine results in decreased activity of CTSD protein CTD PMID:12903910 cis-caffeic acid multiple interactions EXP 6480464 caffeic acid inhibits the reaction [Isoproterenol affects the activity of CTSD protein] CTD PMID:20391626 cisplatin increases expression ISO RGD:732637 6480464 Cisplatin results in increased expression of CTSD mRNA CTD PMID:21151649 cisplatin multiple interactions ISO RGD:1351014 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of CTSD mRNA CTD PMID:27392435 clofibrate decreases expression ISO RGD:732637 6480464 Clofibrate results in decreased expression of CTSD mRNA CTD PMID:17585979 cobalt dichloride increases expression ISO RGD:1351014 6480464 cobaltous chloride results in increased expression of CTSD mRNA CTD PMID:19320972 , PMID:19376846 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of CTSD mRNA, cobaltous chloride results in increased expression of CTSD protein CTD PMID:24386269 cocaine affects expression ISO RGD:732637 6480464 Cocaine affects the expression of CTSD mRNA CTD PMID:15681117 cocaine increases expression EXP 6480464 Cocaine results in increased expression of CTSD protein CTD PMID:25100957 copper atom multiple interactions ISO RGD:1351014 6480464 [Chelating Agents binds to Copper] which results in decreased expression of CTSD mRNA, [NSC 689534 binds to Copper] which results in increased expression of CTSD mRNA CTD PMID:20971185 , PMID:30911355 copper(0) multiple interactions ISO RGD:1351014 6480464 [Chelating Agents binds to Copper] which results in decreased expression of CTSD mRNA, [NSC 689534 binds to Copper] which results in increased expression of CTSD mRNA CTD PMID:20971185 , PMID:30911355 copper(II) chloride decreases expression ISO RGD:732637 6480464 cupric chloride results in decreased expression of CTSD mRNA CTD PMID:32512069 copper(II) chloride multiple interactions ISO RGD:732637 6480464 PP242 inhibits the reaction [cupric chloride results in decreased expression of CTSD mRNA] CTD PMID:32512069 curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [Isoproterenol results in decreased activity of CTSD protein], Curcumin inhibits the reaction [Isoproterenol results in increased activity of CTSD protein] CTD PMID:8534267 curcumin decreases expression ISO RGD:1351014 6480464 Curcumin analog results in decreased expression of CTSD mRNA CTD PMID:26409325 cyclophosphamide multiple interactions ISO RGD:732637 6480464 [Cyclophosphamide co-treated with Mecamylamine] results in increased expression of CTSD mRNA CTD PMID:18433785 cyclophosphamide increases activity EXP 6480464 Cyclophosphamide results in increased activity of CTSD protein CTD PMID:25451569 cyclophosphamide multiple interactions EXP 6480464 Anthocyanins inhibits the reaction [Cyclophosphamide results in increased activity of CTSD protein], Plant Extracts inhibits the reaction [Cyclophosphamide results in increased activity of CTSD protein] CTD PMID:25451569 cyclosporin A increases expression ISO RGD:1351014 6480464 Cyclosporine results in increased expression of CTSD mRNA CTD PMID:20106945 cyproconazole increases expression ISO RGD:732637 6480464 cyproconazole results in increased expression of CTSD mRNA CTD PMID:22334560 cyprodinil increases expression ISO RGD:1351014 6480464 cyprodinil results in increased expression of CTSD protein CTD PMID:26344002 cyprodinil multiple interactions ISO RGD:1351014 6480464 fulvestrant inhibits the reaction [cyprodinil results in increased expression of CTSD protein] CTD PMID:26344002 cysteamine increases expression EXP 6480464 Cysteamine results in increased expression of CTSD protein CTD PMID:20165931 cysteamine multiple interactions EXP 6480464 Omeprazole inhibits the reaction [Cysteamine results in increased expression of CTSD protein], thamira parpam inhibits the reaction [Cysteamine results in increased expression of CTSD protein] CTD PMID:20165931 DDT multiple interactions ISO RGD:1351014 6480464 [DDT results in increased activity of ESR1 protein] which results in increased expression of CTSD mRNA CTD PMID:22403704 Deguelin increases expression ISO RGD:1351014 6480464 deguelin results in increased expression of CTSD mRNA CTD PMID:33512557 dexamethasone increases expression ISO RGD:732637 6480464 Dexamethasone results in increased expression of CTSD mRNA CTD PMID:21041162 dexamethasone decreases expression ISO RGD:1351014 6480464 Dexamethasone results in decreased expression of CTSD mRNA CTD PMID:25047013 dextran sulfate increases expression ISO RGD:732637 6480464 Dextran Sulfate results in increased expression of CTSD protein CTD PMID:32272095 dextran sulfate multiple interactions ISO RGD:732637 6480464 Erianin inhibits the reaction [Dextran Sulfate results in increased expression of CTSD protein] CTD PMID:32272095 diarsenic trioxide increases expression ISO RGD:1351014 6480464 Arsenic Trioxide results in increased expression of CTSD protein CTD PMID:23864846 , PMID:25419056 diarsenic trioxide multiple interactions ISO RGD:1351014 6480464 Arsenic Trioxide promotes the reaction [AG 1879 results in increased expression of CTSD protein] CTD PMID:23864846 diarylheptanoid increases expression ISO RGD:1351014 6480464 Diarylheptanoids results in increased expression of CTSD mRNA CTD PMID:19654927 diarylheptanoid multiple interactions ISO RGD:1351014 6480464 fulvestrant inhibits the reaction [Diarylheptanoids results in increased expression of CTSD mRNA] CTD PMID:19654927 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of CTSD mRNA CTD PMID:17379624 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of CTSD mRNA CTD PMID:15890375 disodium cromoglycate multiple interactions ISO RGD:732637 6480464 [pristane co-treated with Cromolyn Sodium] results in increased expression of CTSD protein CTD PMID:8812242 diuron decreases expression EXP 6480464 Diuron results in decreased expression of CTSD mRNA CTD PMID:21551480 dopamine increases expression ISO RGD:1351014 6480464 Dopamine results in increased expression of CTSD protein CTD PMID:24675778 dorsomorphin multiple interactions ISO RGD:1351014 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CTSD mRNA CTD PMID:27188386 doxorubicin decreases response to substance ISO RGD:1351014 6480464 CTSD protein results in decreased susceptibility to Doxorubicin CTD PMID:18566016 doxorubicin decreases activity EXP 6480464 Doxorubicin results in decreased activity of CTSD protein CTD PMID:12841641 doxorubicin multiple interactions EXP 6480464 Thioctic Acid inhibits the reaction [Doxorubicin results in decreased activity of CTSD protein] CTD PMID:12841641 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of CTSD mRNA CTD PMID:19915844 doxorubicin increases expression ISO RGD:1351014 6480464 Doxorubicin results in increased expression of CTSD mRNA, Doxorubicin results in increased expression of CTSD protein CTD PMID:18566016 , PMID:29803840 ellagic acid multiple interactions EXP 6480464 Ellagic Acid inhibits the reaction [Isoproterenol results in increased activity of CTSD protein] CTD PMID:21762681 emodin decreases expression ISO RGD:1351014 6480464 Emodin results in decreased expression of CTSD mRNA CTD PMID:16045814 enniatin multiple interactions ISO RGD:1351014 6480464 [beauvericin co-treated with enniatins] results in decreased expression of CTSD protein CTD PMID:32407736 epoxiconazole increases expression ISO RGD:732637 6480464 epoxiconazole results in increased expression of CTSD mRNA CTD PMID:22334560 ethambutol multiple interactions EXP 6480464 Ethambutol results in increased expression of and affects the localization of CTSD protein more ... CTD PMID:19063910 fenamidone increases expression ISO RGD:732637 6480464 fenamidone results in increased expression of CTSD mRNA CTD PMID:27029645 fenhexamid multiple interactions ISO RGD:1351014 6480464 fulvestrant inhibits the reaction [N-(2, 3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide results in increased expression of CTSD protein] CTD PMID:26344002 fenhexamid increases expression ISO RGD:1351014 6480464 N-(2, 3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide results in increased expression of CTSD protein CTD PMID:26344002 ferulic acid multiple interactions EXP 6480464 [ferulic acid co-treated with Ascorbic Acid] inhibits the reaction [Isoproterenol results in increased activity of CTSD protein] CTD PMID:17045618 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of CTSD mRNA CTD PMID:18035473 fludioxonil multiple interactions ISO RGD:1351014 6480464 fulvestrant inhibits the reaction [fludioxonil results in increased expression of CTSD protein] CTD PMID:27539251 fludioxonil increases expression ISO RGD:1351014 6480464 fludioxonil results in increased expression of CTSD protein CTD PMID:27539251 flutamide increases expression EXP 6480464 Flutamide results in increased expression of CTSD mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:732637 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CTSD mRNA more ... CTD PMID:20938992 , PMID:22206623 fulvestrant increases expression ISO RGD:1351014 6480464 fulvestrant results in increased expression of CTSD mRNA CTD PMID:15072547 fulvestrant decreases expression ISO RGD:1351014 6480464 fulvestrant results in decreased expression of CTSD mRNA CTD PMID:14750165 fulvestrant multiple interactions ISO RGD:1351014 6480464 Fulvestrant inhibits the reaction [1 more ... CTD PMID:19365803 more ... fumonisin B1 increases expression ISO RGD:732637 6480464 fumonisin B1 results in increased expression of CTSD mRNA CTD PMID:16221962 gamma-terpinene increases expression ISO RGD:1351014 6480464 gamma-terpinene results in increased expression of CTSD mRNA CTD PMID:31393563 genistein increases expression ISO RGD:1351014 6480464 Genistein results in increased expression of CTSD mRNA CTD PMID:10376965 , PMID:15090535 genistein decreases expression ISO RGD:732637 6480464 Genistein results in decreased expression of CTSD mRNA CTD PMID:21048042 genistein multiple interactions ISO RGD:1351014 6480464 Genistein inhibits the reaction [bisphenol A results in increased expression of CTSD protein] more ... CTD PMID:10376965 , PMID:26407941 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of CTSD mRNA CTD PMID:22061828 geraniol multiple interactions EXP 6480464 geraniol inhibits the reaction [4-Nitroquinoline-1-oxide results in increased activity of CTSD protein] CTD PMID:23499697 glyphosate decreases expression ISO RGD:1351014 6480464 glyphosate results in decreased expression of CTSD mRNA CTD PMID:31295307 hydrogen peroxide affects expression ISO RGD:1351014 6480464 Hydrogen Peroxide affects the expression of CTSD protein CTD PMID:21179406 Indeno[1,2,3-cd]pyrene decreases expression ISO RGD:1351014 6480464 indeno(1 more ... CTD PMID:32251684 indole-3-methanol decreases expression ISO RGD:1351014 6480464 indole-3-carbinol results in decreased expression of CTSD protein CTD PMID:11110848 indometacin multiple interactions EXP 6480464 [morin co-treated with Indomethacin] inhibits the reaction [Freund's Adjuvant results in increased activity of CTSD protein] CTD PMID:25698669 isoprenaline multiple interactions EXP 6480464 [ferulic acid co-treated with Ascorbic Acid] inhibits the reaction [Isoproterenol results in increased activity of CTSD protein] more ... CTD PMID:11829124 more ... isoprenaline affects activity EXP 6480464 Isoproterenol affects the activity of CTSD protein CTD PMID:17623887 more ... isoprenaline increases activity EXP 6480464 Isoproterenol results in increased activity of CTSD protein CTD PMID:11829124 more ... isoprenaline decreases activity EXP 6480464 Isoproterenol results in decreased activity of CTSD protein CTD PMID:14499179 more ... isoprenaline increases expression EXP 6480464 Isoproterenol results in increased expression of CTSD mRNA, Isoproterenol results in increased expression of CTSD protein CTD PMID:17182065 more ... ivermectin decreases expression ISO RGD:1351014 6480464 Ivermectin results in decreased expression of CTSD protein CTD PMID:32959892 kainic acid multiple interactions EXP 6480464 NADP inhibits the reaction [Kainic Acid results in increased expression of CTSD protein] CTD PMID:32057834 kainic acid increases expression EXP 6480464 Kainic Acid results in increased expression of CTSD protein CTD PMID:32057834 L-ascorbic acid multiple interactions EXP 6480464 [ferulic acid co-treated with Ascorbic Acid] inhibits the reaction [Isoproterenol results in increased activity of CTSD protein] CTD PMID:17045618 L-methionine multiple interactions ISO RGD:732637 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CTSD mRNA CTD PMID:20938992 lead(0) affects expression ISO RGD:1351014 6480464 Lead affects the expression of CTSD mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:1351014 6480464 Lead affects the expression of CTSD mRNA CTD PMID:28903495 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of CTSD mRNA CTD PMID:24136188 limonene increases expression ISO RGD:1351014 6480464 Limonene results in increased expression of CTSD mRNA CTD PMID:31393563 limonene multiple interactions ISO RGD:1351014 6480464 Fulvestrant inhibits the reaction [Limonene results in increased expression of CTSD mRNA] CTD PMID:31393563 linalool increases expression ISO RGD:1351014 6480464 linalool results in increased expression of CTSD mRNA CTD PMID:19922762 , PMID:31393563 linalool multiple interactions ISO RGD:1351014 6480464 Fulvestrant inhibits the reaction [linalool results in increased expression of CTSD mRNA] CTD PMID:31393563 linalyl acetate multiple interactions ISO RGD:1351014 6480464 Fulvestrant inhibits the reaction [linalyl acetate results in increased expression of CTSD mRNA] CTD PMID:31393563 linalyl acetate increases expression ISO RGD:1351014 6480464 linalyl acetate results in increased expression of CTSD mRNA CTD PMID:31393563 lipoic acid multiple interactions EXP 6480464 Thioctic Acid inhibits the reaction [Doxorubicin results in decreased activity of CTSD protein] CTD PMID:12841641 lipopolysaccharide increases expression ISO RGD:732637 6480464 Lipopolysaccharides results in increased expression of CTSD mRNA CTD PMID:15919760 lithium atom increases expression EXP 6480464 Lithium results in increased expression of CTSD protein CTD PMID:18296634 lithium hydride increases expression EXP 6480464 Lithium results in increased expression of CTSD protein CTD PMID:18296634 lucanthone increases expression ISO RGD:1351014 6480464 Lucanthone results in increased expression of CTSD mRNA, Lucanthone results in increased expression of CTSD protein CTD PMID:21148553 malathion increases expression ISO RGD:732637 6480464 Malathion results in increased expression of CTSD protein CTD PMID:8812242 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of CTSD protein CTD PMID:28378122 manganese(II) chloride affects localization EXP 6480464 manganese chloride affects the localization of CTSD protein CTD PMID:28378122 mangiferin multiple interactions EXP 6480464 mangiferin inhibits the reaction [Isoproterenol results in decreased activity of CTSD protein] CTD PMID:19172585 Mecamylamine multiple interactions ISO RGD:732637 6480464 [Cyclophosphamide co-treated with Mecamylamine] results in increased expression of CTSD mRNA CTD PMID:18433785 medroxyprogesterone acetate increases expression ISO RGD:1351014 6480464 Medroxyprogesterone Acetate results in increased expression of CTSD mRNA CTD PMID:18497975 melatonin multiple interactions ISO RGD:1351014 6480464 Melatonin inhibits the reaction [Cadmium Chloride results in increased expression of CTSD] CTD PMID:22041583 methamphetamine affects localization EXP 6480464 Methamphetamine affects the localization of CTSD protein CTD PMID:17105920 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of CTSD mRNA CTD PMID:15890375 miconazole increases expression ISO RGD:1351014 6480464 Miconazole results in increased expression of CTSD protein CTD PMID:32981224 morin multiple interactions EXP 6480464 [morin co-treated with Indomethacin] inhibits the reaction [Freund's Adjuvant results in increased activity of CTSD protein], morin inhibits the reaction [Freund's Adjuvant results in increased activity of CTSD protein] CTD PMID:25698669 morusin decreases metabolic processing ISO RGD:1351014 6480464 morusin results in decreased metabolism of CTSD protein CTD PMID:29421517 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine multiple interactions EXP 6480464 N more ... CTD PMID:19063910 N-acetylsphingosine increases secretion EXP 6480464 N-acetylsphingosine results in increased secretion of CTSD protein CTD PMID:15040013 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of CTSD mRNA CTD PMID:15890375 N-tosyl-L-phenylalanyl chloromethyl ketone increases expression ISO RGD:1351014 6480464 Tosylphenylalanyl Chloromethyl Ketone results in increased expression of CTSD protein CTD PMID:10772776 NADP zwitterion multiple interactions EXP 6480464 NADP inhibits the reaction [Kainic Acid results in increased expression of CTSD protein] CTD PMID:32057834 NADP(+) multiple interactions EXP 6480464 NADP inhibits the reaction [Kainic Acid results in increased expression of CTSD protein] CTD PMID:32057834 naphthalenes decreases expression EXP 6480464 Naphthalenes results in decreased expression of CTSD protein CTD PMID:17337753 naringin multiple interactions EXP 6480464 naringin inhibits the reaction [Isoproterenol results in increased activity of CTSD protein] CTD PMID:17188415 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of CTSD mRNA CTD PMID:24136188 niclosamide decreases expression ISO RGD:1351014 6480464 Niclosamide results in decreased expression of CTSD protein CTD PMID:29480568 nicorandil multiple interactions EXP 6480464 [Nicorandil co-treated with Amlodipine] inhibits the reaction [Isoproterenol results in decreased activity of CTSD protein], [Nicorandil co-treated with Amlodipine] inhibits the reaction [Isoproterenol results in increased activity of CTSD protein] CTD PMID:11829124 , PMID:14499179 nitric oxide increases secretion EXP 6480464 Nitric Oxide results in increased secretion of CTSD protein CTD PMID:15040013 nitroglycerin decreases expression EXP 6480464 Nitroglycerin results in decreased expression of CTSD mRNA CTD PMID:12102619 Nonylphenol multiple interactions ISO RGD:1351014 6480464 [nonylphenol results in increased activity of ESR1 protein] which results in increased expression of CTSD mRNA more ... CTD PMID:14754635 more ... Nonylphenol increases expression ISO RGD:1351014 6480464 nonylphenol results in increased expression of CTSD protein CTD PMID:26407941 omeprazole multiple interactions EXP 6480464 Omeprazole inhibits the reaction [Cysteamine results in increased expression of CTSD protein] CTD PMID:20165931 ozone multiple interactions ISO RGD:1351014 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CTSD mRNA more ... CTD PMID:32699268 p-tert-Amylphenol increases expression ISO RGD:1351014 6480464 4-tert-octylphenol results in increased expression of CTSD mRNA, 4-tert-octylphenol results in increased expression of CTSD protein CTD PMID:23219593 p-tert-Amylphenol multiple interactions ISO RGD:1351014 6480464 ESR1 mutant form inhibits the reaction [4-tert-octylphenol results in increased expression of CTSD mRNA], Fulvestrant inhibits the reaction [4-tert-octylphenol results in increased expression of CTSD mRNA] CTD PMID:23219593 paracetamol increases expression ISO RGD:732637 6480464 Acetaminophen results in increased expression of CTSD protein CTD PMID:8794998 paracetamol affects expression ISO RGD:732637 6480464 Acetaminophen affects the expression of CTSD mRNA CTD PMID:17562736 paraquat decreases expression ISO RGD:732637 6480464 Paraquat results in decreased expression of CTSD mRNA CTD PMID:16797015 pepstatin A multiple interactions ISO RGD:1351014 6480464 [aloxistatin co-treated with pepstatin] results in decreased expression of CTSD protein more ... CTD PMID:16850161 , PMID:32186374 pepstatin A decreases activity EXP 6480464 pepstatin results in decreased activity of CTSD protein CTD PMID:6497855 pepstatin A decreases activity ISO RGD:1351014 6480464 pepstatin results in decreased activity of CTSD protein CTD PMID:11423908 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:732637 6480464 perfluorooctane sulfonic acid results in decreased expression of CTSD protein CTD PMID:32861759 perfluorooctanoic acid multiple interactions ISO RGD:1351014 6480464 [Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in decreased expression of CTSD mRNA CTD PMID:33325755 phenacetin increases expression EXP 6480464 Phenacetin results in increased expression of CTSD mRNA CTD PMID:17698508 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of CTSD mRNA CTD PMID:19162173 phenylhydrazine increases expression EXP 6480464 phenylhydrazine results in increased expression of CTSD mRNA CTD PMID:17698508 phenylmercury acetate multiple interactions ISO RGD:1351014 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CTSD mRNA CTD PMID:27188386 PhIP increases expression ISO RGD:1351014 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of CTSD protein CTD PMID:20951759 PhIP multiple interactions EXP 6480464 [2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine co-treated with Dietary Fats] results in decreased expression of CTSD mRNA CTD PMID:12097258 phytoestrogen multiple interactions ISO RGD:1351014 6480464 [Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in decreased expression of CTSD mRNA CTD PMID:33325755 picene decreases expression ISO RGD:1351014 6480464 picene results in decreased expression of CTSD mRNA CTD PMID:32251684 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of CTSD mRNA CTD PMID:15890375 , PMID:22484513 pirimiphos-methyl decreases activity EXP 6480464 pirimiphos methyl results in decreased activity of CTSD protein CTD PMID:9204212 pirimiphos-methyl increases activity EXP 6480464 pirimiphos methyl results in increased activity of CTSD protein CTD PMID:9204212 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of CTSD mRNA CTD PMID:15890375 , PMID:19162173 pirinixic acid increases expression ISO RGD:732637 6480464 pirinixic acid results in increased expression of CTSD mRNA CTD PMID:18301758 more ... pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of CTSD mRNA CTD PMID:19162173 pristane increases expression ISO RGD:732637 6480464 pristane results in increased expression of CTSD protein CTD PMID:8812242 pristane multiple interactions ISO RGD:732637 6480464 [pristane co-treated with Cromolyn Sodium] results in increased expression of CTSD protein CTD PMID:8812242 progesterone increases expression ISO RGD:1351014 6480464 Progesterone results in increased expression of CTSD mRNA CTD PMID:18497975 propiconazole increases expression ISO RGD:732637 6480464 propiconazole results in increased expression of CTSD mRNA CTD PMID:22334560 quercetin multiple interactions ISO RGD:1351014 6480464 Quercetin inhibits the reaction [Estradiol results in increased expression of CTSD mRNA], Quercetin inhibits the reaction [Genistein results in increased expression of CTSD mRNA] CTD PMID:10376965 quercetin increases expression ISO RGD:1351014 6480464 Quercetin results in increased expression of CTSD mRNA CTD PMID:15090535 , PMID:21632981 quizartinib multiple interactions ISO RGD:1351014 6480464 [quizartinib co-treated with spautin-1 co-treated with Chloroquine] results in increased transport of and affects the localization of CTSD protein CTD PMID:30821613 resveratrol increases expression ISO RGD:1351014 6480464 resveratrol metabolite results in increased expression of CTSD mRNA more ... CTD PMID:10402233 more ... resveratrol decreases expression ISO RGD:1351014 6480464 resveratrol results in decreased expression of CTSD mRNA CTD PMID:14750165 resveratrol increases expression ISO RGD:732637 6480464 resveratrol results in increased expression of CTSD mRNA CTD PMID:16081268 resveratrol increases secretion ISO RGD:1351014 6480464 resveratrol results in increased secretion of CTSD protein CTD PMID:16393696 resveratrol affects expression ISO RGD:1351014 6480464 resveratrol affects the expression of CTSD mRNA CTD PMID:16393696 resveratrol affects response to substance ISO RGD:1351014 6480464 CTSD protein affects the susceptibility to resveratrol CTD PMID:17116725 resveratrol multiple interactions ISO RGD:1351014 6480464 [resveratrol results in increased expression of IGF2 protein] which results in increased secretion of CTSD protein more ... CTD PMID:16393696 , PMID:17116725 retinyl acetate increases expression ISO RGD:732637 6480464 retinol acetate results in increased expression of CTSD mRNA CTD PMID:16772331 rotenone affects expression ISO RGD:732637 6480464 Rotenone affects the expression of CTSD mRNA CTD PMID:23186747 S-allylcysteine multiple interactions EXP 6480464 S-allylcysteine inhibits the reaction [Isoproterenol results in increased expression of CTSD mRNA] CTD PMID:17182065 sarin decreases expression ISO RGD:1351014 6480464 Sarin results in decreased expression of CTSD mRNA CTD PMID:19522546 SB 431542 multiple interactions ISO RGD:1351014 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CTSD mRNA CTD PMID:27188386 silicon dioxide affects secretion ISO RGD:1351014 6480464 Silicon Dioxide analog affects the secretion of CTSD protein CTD PMID:25895662 silicon dioxide increases expression ISO RGD:732637 6480464 Silicon Dioxide results in increased expression of CTSD mRNA CTD PMID:29203145 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of CTSD mRNA CTD PMID:32721576 sodium arsenate increases expression ISO RGD:732637 6480464 sodium arsenate results in increased expression of CTSD mRNA CTD PMID:30953684 sodium arsenite increases activity ISO RGD:1351014 6480464 sodium arsenite results in increased activity of CTSD protein CTD PMID:20816728 sodium arsenite increases expression ISO RGD:1351014 6480464 sodium arsenite results in increased expression of CTSD mRNA, sodium arsenite results in increased expression of CTSD protein CTD PMID:20050688 , PMID:20816728 sodium fluoride decreases expression ISO RGD:732637 6480464 Sodium Fluoride results in decreased expression of CTSD protein CTD PMID:28918527 Soman increases expression EXP 6480464 Soman results in increased expression of CTSD mRNA CTD PMID:19281266 stilben-4-ol increases expression ISO RGD:1351014 6480464 4-hydroxystilbene results in increased expression of CTSD mRNA CTD PMID:19496085 stilbene-4,4'-diol increases expression ISO RGD:1351014 6480464 4, 4'-dihydroxystilbene results in increased expression of CTSD mRNA CTD PMID:19496085 swainsonine decreases expression EXP 6480464 Swainsonine results in decreased expression of CTSD protein CTD PMID:33186601 tamibarotene increases expression ISO RGD:1351014 6480464 tamibarotene results in increased expression of CTSD mRNA CTD PMID:15498508 tamoxifen multiple interactions ISO RGD:1351014 6480464 benzamide analog inhibits the reaction [Tamoxifen promotes the reaction [ESR1 protein binds to CTSD promoter]], Tamoxifen promotes the reaction [ESR1 protein binds to CTSD promoter] CTD PMID:17157789 tea tree oil increases expression ISO RGD:1351014 6480464 Tea Tree Oil results in increased expression of CTSD mRNA CTD PMID:31393563 tea tree oil multiple interactions ISO RGD:1351014 6480464 Fulvestrant inhibits the reaction [Tea Tree Oil results in increased expression of CTSD mRNA] CTD PMID:31393563 temozolomide decreases expression ISO RGD:1351014 6480464 Temozolomide results in decreased expression of CTSD mRNA CTD PMID:31758290 tetrachloromethane increases expression ISO RGD:732637 6480464 Carbon Tetrachloride results in increased expression of CTSD mRNA CTD PMID:27339419 , PMID:31919559 titanium dioxide decreases expression ISO RGD:732637 6480464 titanium dioxide results in decreased expression of CTSD mRNA CTD PMID:23557971 titanium dioxide decreases expression ISO RGD:1351014 6480464 titanium dioxide results in decreased expression of CTSD protein CTD PMID:30910687 titanium dioxide increases expression ISO RGD:732637 6480464 titanium dioxide results in increased expression of CTSD mRNA CTD PMID:27760801 trans-caffeic acid multiple interactions EXP 6480464 caffeic acid inhibits the reaction [Isoproterenol affects the activity of CTSD protein] CTD PMID:20391626 trans-stilbene-4,4'-diol increases expression ISO RGD:1351014 6480464 4, 4'-dihydroxystilbene results in increased expression of CTSD mRNA CTD PMID:19496085 triclosan increases expression ISO RGD:1351014 6480464 Triclosan results in increased expression of CTSD protein CTD PMID:28844962 triclosan multiple interactions ISO RGD:1351014 6480464 3 more ... CTD PMID:28844962 triptonide increases expression ISO RGD:732637 6480464 triptonide results in increased expression of CTSD mRNA CTD PMID:33045310 tunicamycin increases expression ISO RGD:1351014 6480464 Tunicamycin results in increased expression of CTSD mRNA CTD PMID:22378314 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of CTSD mRNA CTD PMID:24136188 valproic acid increases methylation ISO RGD:1351014 6480464 Valproic Acid results in increased methylation of CTSD gene CTD PMID:29154799 valproic acid increases expression ISO RGD:1351014 6480464 Valproic Acid results in increased expression of CTSD mRNA CTD PMID:23179753 valproic acid decreases expression ISO RGD:1351014 6480464 Valproic Acid results in decreased expression of CTSD mRNA CTD PMID:29154799 vancomycin decreases expression ISO RGD:732637 6480464 Vancomycin results in decreased expression of CTSD mRNA CTD PMID:18930951 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of CTSD mRNA CTD PMID:22570695 vorinostat increases expression ISO RGD:1351014 6480464 vorinostat results in increased expression of CTSD protein CTD PMID:20543569 WIN 55212-2 increases expression ISO RGD:1351014 6480464 (3R)-((2 more ... CTD PMID:30776504 Yessotoxin increases expression ISO RGD:1351014 6480464 yessotoxin analog results in increased expression of CTSD mRNA CTD PMID:30679557 zearalenone increases expression ISO RGD:1351014 6480464 Zearalenone results in increased expression of CTSD mRNA CTD PMID:28965971 zinc pyrithione increases expression ISO RGD:1351014 6480464 pyrithione zinc results in increased expression of CTSD protein CTD PMID:20151177
